Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir
分析接受羟氯喹或法匹拉韦治疗的中重度 COVID-19 患者住院时间 (LOS) 的差异
期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph15121456
Alosaimi, Bandar; Alshanbari, Huda M; Alturaiqy, Muath; AlRawi, Halah Z; Alamri, Saad; Albujaidy, Asma; Bin Sabaan, Aljawharah; Alrashed, Ahmed A; Alamer, Ahmad; Alghofaili, Fayez; Al-Duraymih, Khaled; Alshalani, Abdulaziz J; Alturaiki, Wael